Nov 06, 2019
ANI Pharmaceuticals Reports Third Quarter Results
Oct 31, 2019
ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias
Oct 29, 2019
ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business
Oct 03, 2019
ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study
Sep 11, 2019
ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL
Aug 07, 2019
ANI Pharmaceuticals Reports Second Quarter Results
Jul 31, 2019
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results
Jun 25, 2019
ANI Pharmaceuticals Announces Launch of Ranitidine Capsules
Jun 20, 2019
ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml
Jun 18, 2019
ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
Jun 12, 2019
ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference
May 02, 2019
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results
Apr 15, 2019
ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product
Mar 27, 2019
ANI Pharmaceuticals Announces Two Generic Product Launches
Feb 20, 2019
ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2018 Financial Results
Dec 27, 2018
ANI Pharmaceuticals Secures Refinancing for Convertible Debt Due December 2019 and Enters Amended Five-Year $265 Million Senior Secured Credit Facility
Dec 07, 2018
ANI Pharmaceuticals Enters into Separate Privately Negotiated Agreements with Certain Holders of its Convertible Notes
Nov 15, 2018
ANI Pharmaceuticals, Inc. Ranked Number 366 Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500(TM)
Nov 06, 2018
ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance
Oct 30, 2018
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2018 Financial Results